Skip to main content

Fiona

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Fiona

Fiona is recorded as Analyst at Jefferies. Fiona has spoken on 3 earnings calls and 2 other investor events across 5 companies, most recently for MBX Biosciences, Inc. on June 3, 2026. Those appearances were for MBX Biosciences, Inc. (MBX), Autolus Therapeutics plc (AUTL), BioAge Labs, Inc. (BIOA), JELD-WEN Holding, Inc. (JELD) and Armstrong World Industries Inc (AWI). The companies whose calls Fiona spoke on are classified in the Healthcare and Industrials sectors.

Fiona on recent calls

“I cover spring cap biotech companies at Jeffrey's, and it is my greatest pleasure to welcome to the stage with me MBX Bioscience CEO, Ken Harlock, and CMO, Dr. Sam Osley.”
Analyst — Jefferies, Jefferies Global Healthcare Conference ·
“This is day one of Jeffrey's Global Healthcare Conference. My name is Fiona. I cover SMICAP, biotech companies at Jeffrey's. And it is my greatest pleasure to welcome to this fireside chat with me from Atalus Therapeutics CEO, Christian Aitem.”
Analyst — Jefferies, JEFFERIES GLOBAL HEALTHCARE CONFERENCE ·
“My question is also somewhat related to the dose response between the 60 and 120. Is it possible that you're hitting an efficacy ceiling even at 60 because both response seems to be good.”
Analyst — Jefferies, BioAge Labs, Inc. Q1 FY2026 Earnings Call ·
“We saw the volumes on North America were much better than expected.”
Analyst — Jefferies, JELD-WEN Holding, Inc. Q2 FY2025 Earnings Call ·
“How do you expect the recent tariff on steel and aluminum to impact your wave earnings in 2025? Just wondering do you have the ability to push price higher?”
Analyst — Jefferies, Armstrong World Industries Inc Q4 FY2024 Earnings Call ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity